Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (5): 639-648.doi: 10.12092/j.issn.1009-2501.2026.05.008

Previous Articles     Next Articles

Construction strategy and application of an in vitro model of radioactive cardiac injury

Xiaying WANG1(), Hugang JIANG1,2,3, Chunzhen REN1,2, Jing MA1, Jiakun LIU1, Kai LIU1,2,3, Yingdong LI1,2,3, Xinke ZHAO1,2,3,*()   

  1. 1. College of Integrated Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu, China
    2. Gansu Provincial Key Laboratory of Traditional Chinese Medicine for Chronic Disease Prevention and Treatment, Lanzhou 730000, Gansu, China
    3. Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou 730000, Gansu, China
  • Received:2025-06-29 Revised:2025-09-03 Online:2026-05-26 Published:2026-06-02
  • Contact: Xinke ZHAO E-mail:1686610858@qq.com;zxkd412@163.com

Abstract:

Radiation-induced heart disease is the most common and severe complication of radiation therapy for thoracic tumours. After exposure to radiation, cardiac tissue undergoes myocardial inflammation, fibrosis, and vascular endothelial damage, leading to cardiac dysfunction. With the continuous improvement of medical technology, the survival period of tumour patients has been significantly extended. However, RIHD severely impacts patients' quality of life. To thoroughly investigate its pathological mechanisms, establishing a reliable RIHD cell model is a crucial experimental foundation for studying its molecular mechanisms and evaluating treatment efficacy. This article reviews and summarises the application and research progress of RIHD cell models in related studies both domestically and internationally in recent years, aiming to provide a reliable theoretical basis for RIHD research.

Key words: radiation-induced, cellular model, standardization, drug screening

CLC Number: